Key facts
- It has raised $14.0M; the latest was Later Stage VC ($14.0M) in Oct 2025.
- Notable investors include Suzhou Oriza Holdings Corporation, HSG (Hong Kong), Lotus Lake Ventures, Shanghai Guofang Private Equity Fund Management Company, Ennovation Ventures — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Null Hypothesis
- ·The full record, as it builds
Funding rounds
No funding rounds for Null Hypothesis are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Null Hypothesis
Developer of AI high-performance computing chips intended for data centers, cloud computing, and central-side servers. The company's chips feature memristor-based designs, heterogeneous architecture, and low-power operation, thereby offering enhanced energy efficiency, cost-effectiveness, and computing power for next-generation AI workloads.
- Sector
- Healthcare
- HQ
- Hangzhou, China
- Founded
- 2019
- Website
- nullht.com/
- Ownership
- Privately Held (backing)
Null Hypothesis doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Null Hypothesis shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Null Hypothesis in its N-PORT filings yet. We sweep new filings monthly.